Tue, November 14, 2023

Gregory Renza Reiterated (VRDN) at Buy and Held Target at $35 on, Nov 14th, 2023

Gregory Renza of RBC Capital, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $35 on, Nov 14th, 2023.

Gregory has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Gregory


  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $37 on, Tuesday, October 31st, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, October 30th, 2023
  • Alex Thompson of "Stifel" Reiterated at Strong Buy and Held Target at $40 on, Wednesday, September 13th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Thursday, August 10th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023